Table 4.
Drug classes or combinations of class prescribed during first year of antt-hypertenave medication use by disease category.a
| DISEASE CATEGORY | DRUG CLASSES | PERCENT |
|---|---|---|
|
| ||
| Hypertension alone | Angiotensin receptor blocker | 25.9% |
| Beta blocker | 18.5% | |
| ACE 1 inhibitor | 18.2% | |
| Calcium channel blocker | 10.4% | |
| Thiazide diuretics | 10.4% | |
| ACE 1 inhibitor & calcium channel blocker combination | 2.6% | |
| Ace 1 inhibitor & beta blocker | 2.3% | |
|
| ||
| Diabetes | ACE 1 inhibitor | 31.9% |
| Beta blocker | 16.2% | |
| Angiotensin receptor blocker | 12.9% | |
| Ace 1 inhibitor & beta blocker | 8.5% | |
| Calcium channel blocker | 7.8% | |
| Thiazide diuretics | 4.1% | |
| ACE 1 inhibitor & Angiotensin receptor blocker | 3.9% | |
|
| ||
| Congestive heart failure | ACE 1 inhibitor | 39.9% |
| Angiotensin receptor blocker | 27.3% | |
| Beta blocker | 6.8% | |
| ACE 1 inhibitor & Angiotensin receptor blocker | 5.5% | |
| Calcium channel blocker | 4.4% | |
| Thiazide diuretics | 3.8% | |
a
Table lists all drug classes or combinations used by 2% or more of patients in a disease category. Ampersand separates different drug classes used by patients during year, and not necessarily at the same time.